Alternative Vascularization Mechanisms in Tumor Resistance to Therapy.

antiangiogenic therapy drug resistance non-sprouting angiogenesis tumor microenvironment tumor vasculature

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
15 Apr 2021
Historique:
received: 18 03 2021
revised: 12 04 2021
accepted: 13 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

Blood vessels in tumors are formed through a variety of different mechanisms, each generating vessels with peculiar structural, molecular, and functional properties. This heterogeneity has a major impact on tumor response or resistance to antineoplastic therapies and is now emerging as a promising target for strategies to prevent drug resistance and improve the distribution and efficacy of antineoplastic treatments. This review presents evidence of how different mechanisms of tumor vessel formation (vasculogenesis, glomeruloid proliferation, intussusceptive angiogenesis, vasculogenic mimicry, and vessel co-option) affect tumor responses to antiangiogenic and antineoplastic therapies, but also how therapies can promote alternative mechanisms of vessel formation, contributing to tumor recurrence, malignant progression, and acquired drug resistance. We discuss the possibility of tailoring treatment strategies to overcome vasculature-mediated drug resistance or to improve drug distribution and efficacy.

Identifiants

pubmed: 33921099
pii: cancers13081912
doi: 10.3390/cancers13081912
pmc: PMC8071410
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG2018-21359
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG 2019-23443

Références

Front Immunol. 2020 Nov 11;11:584723
pubmed: 33262763
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12917-22
pubmed: 14561896
Cancer Res. 2010 Jul 15;70(14):5679-85
pubmed: 20631066
Autophagy. 2017 Sep 2;13(9):1528-1542
pubmed: 28812437
Proc Natl Acad Sci U S A. 2008 May 6;105(18):6620-5
pubmed: 18443294
Adv Drug Deliv Rev. 2019 Feb 15;141:67-91
pubmed: 30201522
J Pathol Clin Res. 2019 Jan;5(1):53-62
pubmed: 30225999
Cancer Cell. 2008 Sep 9;14(3):263-73
pubmed: 18772115
J Clin Invest. 2021 Jan 19;131(2):
pubmed: 33258803
J Res Med Sci. 2017 Oct 31;22:117
pubmed: 29184575
Science. 2006 Sep 22;313(5794):1785-7
pubmed: 16990548
Cancer Cell. 2008 Mar;13(3):193-205
pubmed: 18328424
Adv Cancer Res. 2020;148:27-67
pubmed: 32723566
Angiogenesis. 2020 Feb;23(1):55-74
pubmed: 31865479
Neoplasia. 2018 Oct;20(10):1070-1082
pubmed: 30236892
Semin Cancer Biol. 2021 Jun;71:52-64
pubmed: 32920126
Microvasc Res. 1996 Mar;51(2):260-72
pubmed: 8778579
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Oncotarget. 2016 Jun 21;7(25):38467-86
pubmed: 27509260
Nat Rev Clin Oncol. 2018 May;15(5):310-324
pubmed: 29434333
Sci Rep. 2021 Feb 9;11(1):3388
pubmed: 33564016
Stem Cells Int. 2018 Nov 18;2018:9847015
pubmed: 30581475
EMBO Rep. 2018 May;19(5):
pubmed: 29643120
Cancers (Basel). 2019 May 29;11(6):
pubmed: 31146471
Mol Cancer. 2014 Sep 08;13:207
pubmed: 25200065
Angiogenesis. 2016 Apr;19(2):191-200
pubmed: 26899730
Nat Rev Clin Oncol. 2019 Aug;16(8):469-493
pubmed: 30816337
Cancer Res. 2002 Jul 15;62(14):4015-22
pubmed: 12124335
Nat Rev Cancer. 2019 Dec;19(12):667-685
pubmed: 31645711
PLoS One. 2013 Nov 11;8(11):e78675
pubmed: 24244338
Angiogenesis. 2021 Feb;24(1):57-65
pubmed: 33037487
Oncotarget. 2017 Jun 13;8(24):39795-39804
pubmed: 26950275
Cancer Biol Ther. 2017 Apr 3;18(4):205-213
pubmed: 28278077
Neoplasia. 2000 Jul-Aug;2(4):306-14
pubmed: 11005565
Cancer Cell. 2008 Mar;13(3):206-20
pubmed: 18328425
Cancer Res. 2002 Dec 1;62(23):6808-11
pubmed: 12460889
Cancer Cell. 2020 Mar 16;37(3):421
pubmed: 32183954
Am J Pathol. 1997 Nov;151(5):1417-23
pubmed: 9358768
Br J Cancer. 2011 Jun 28;105(1):9-12
pubmed: 21673677
Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1402-1418
pubmed: 31242036
Cancer Res. 2006 Sep 15;66(18):9054-64
pubmed: 16982747
J Hematol Oncol. 2020 Mar 14;13(1):19
pubmed: 32169087
Cancer. 2001 Apr 15;91(8):1500-9
pubmed: 11301398
J Cell Mol Med. 2009 Feb;13(2):309-319
pubmed: 18410528
F1000Res. 2018 Mar 15;7:326
pubmed: 29560266
Stem Cell Rev. 2008 Sep;4(3):169-77
pubmed: 18607782
JCI Insight. 2020 Oct 2;5(19):
pubmed: 33004686
Hum Pathol. 1998 Apr;29(4):352-8
pubmed: 9563784
Nat Rev Cancer. 2018 May;18(5):323-336
pubmed: 29520090
Cancer Res. 2018 Jan 15;78(2):489-500
pubmed: 29183891
Cancer Res. 2011 Nov 15;71(22):7021-8
pubmed: 21937680
Cancer J. 2015 Jul-Aug;21(4):237-43
pubmed: 26222073
Biomed Pharmacother. 2019 Mar;111:602-612
pubmed: 30611984
Cancer Cell. 2018 May 14;33(5):874-889.e7
pubmed: 29681511
Cancer Res. 2011 Jan 1;71(1):19-28
pubmed: 21199795
Circ Res. 2020 Jul 3;127(2):310-329
pubmed: 32833569
FASEB J. 2006 Jul;20(9):1495-7
pubmed: 16754748
J Clin Invest. 2018 Jul 2;128(7):2927-2943
pubmed: 29863500
J Cell Mol Med. 2019 Jun;23(6):3916-3926
pubmed: 30950188
Science. 2016 Jun 17;352(6292):1381-3
pubmed: 27313019
Genes Dev. 2007 Jun 15;21(12):1546-58
pubmed: 17575055
Clin Cancer Res. 1996 Nov;2(11):1843-9
pubmed: 9816139
Angiogenesis. 2020 Feb;23(1):9-16
pubmed: 31679081
Angiogenesis. 2018 Nov;21(4):883-900
pubmed: 30014172
Angiogenesis. 2012 Dec;15(4):685-95
pubmed: 22914877
Cochrane Database Syst Rev. 2018 Nov 22;11:CD008218
pubmed: 30480778
Nature. 2010 Dec 9;468(7325):824-8
pubmed: 21102434
Am J Pathol. 1999 Sep;155(3):739-52
pubmed: 10487832
Cancer Res. 2015 Apr 15;75(8):1682-90
pubmed: 25769726
J Cell Biochem. 2020 Feb 14;:
pubmed: 32056279
Annu Rev Physiol. 2019 Feb 10;81:505-534
pubmed: 30742782
Int J Nanomedicine. 2020 Aug 25;15:6451-6468
pubmed: 32922011
Cancer Cell. 2014 Mar 17;25(3):350-65
pubmed: 24651014
J Pathol. 2017 Feb;241(3):362-374
pubmed: 27859259
Sci Rep. 2016 Mar 15;6:23056
pubmed: 26976322
Int J Cancer. 2015 Mar 15;136(6):E545-58
pubmed: 25284767
Am J Pathol. 2001 Mar;158(3):1145-60
pubmed: 11238063
Cancer Cell. 2017 Apr 10;31(4):501-515.e8
pubmed: 28399408
Nat Med. 2016 Nov;22(11):1294-1302
pubmed: 27748747
Lancet. 2016 Jul 30;388(10043):518-29
pubmed: 26853587
Chin J Cancer. 2016 Nov 25;35(1):97
pubmed: 27887628
J Clin Invest. 2020 Aug 3;130(8):4055-4068
pubmed: 32369453
Cell Mol Life Sci. 2020 May;77(9):1745-1770
pubmed: 31690961
Cancer Treat Rev. 2020 Jun;86:102017
pubmed: 32335505
Cell Rep. 2020 Jun 16;31(11):107765
pubmed: 32553158
Ann Thorac Surg. 2008 Feb;85(2):395-405
pubmed: 18222232
Microvasc Res. 2018 Sep;119:47-59
pubmed: 29649432
Nat Rev Cancer. 2005 Jun;5(6):436-46
pubmed: 15928674
Mol Oncol. 2014 Jul;8(5):968-81
pubmed: 24747080
J Pathol Clin Res. 2018 Jul;4(3):184-192
pubmed: 29654716
Gastroenterology. 2012 Apr;142(4):967-977.e2
pubmed: 22245843
Int J Dev Biol. 2011;55(4-5):563-7
pubmed: 21858777
J Pathol. 2012 Nov;228(3):378-90
pubmed: 22786655
EMBO Mol Med. 2020 Feb 7;12(2):e10862
pubmed: 31793743
Scanning. 2014 May-Jun;36(3):293-300
pubmed: 23801220
Nat Rev Neurosci. 2007 Aug;8(8):610-22
pubmed: 17643088
Cancer Lett. 2012 Mar 28;316(2):126-31
pubmed: 22197620
Sci Rep. 2018 Jun 29;8(1):9840
pubmed: 29959335
Transl Oncol. 2017 Aug;10(4):650-660
pubmed: 28668763
Breast Cancer Res. 2019 Aug 6;21(1):88
pubmed: 31387614
Acta Biomater. 2019 Aug;94:495-504
pubmed: 31252171
Chin J Cancer. 2016 Feb 12;35:18
pubmed: 26873439
J Clin Invest. 2010 Mar;120(3):663-7
pubmed: 20179347
Am J Pathol. 2011 Sep;179(3):1573-85
pubmed: 21827961
Stem Cells Int. 2016;2016:7954580
pubmed: 26788072
Front Oncol. 2020 Feb 27;10:221
pubmed: 32175278
Am J Pathol. 2008 Oct;173(4):1173-85
pubmed: 18787105
FASEB J. 2019 Jan;33(1):34-48
pubmed: 30085886
Biochim Biophys Acta. 2006 Aug;1766(1):159-66
pubmed: 16857321
J Natl Cancer Inst. 2016 Apr 08;108(8):
pubmed: 27059374
J Clin Invest. 2010 Mar;120(3):694-705
pubmed: 20179352
Histopathology. 2001 May;38(5):466-70
pubmed: 11422485
Angiogenesis. 2018 Aug;21(3):425-532
pubmed: 29766399
Angiogenesis. 2020 Feb;23(1):43-54
pubmed: 31655928
Int J Cancer. 2019 Oct 15;145(8):2157-2169
pubmed: 30924128
Cancer Rep (Hoboken). 2020 Dec 9;:e1318
pubmed: 33295149
Cancer Med. 2013 Aug;2(4):427-36
pubmed: 24156015
J Natl Cancer Inst. 2012 Jun 20;104(12):899-905
pubmed: 22572994
Angiogenesis. 2013 Oct;16(4):921-37
pubmed: 23881168
Angiogenesis. 2020 Feb;23(1):3-8
pubmed: 31701335
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2662-2671
pubmed: 30700544
Int J Nanomedicine. 2016 Mar 21;11:1131-46
pubmed: 27042063
J Pathol. 2018 Dec;246(4):447-458
pubmed: 30101525
J Theor Biol. 2006 Jul 7;241(1):94-108
pubmed: 16388825
Am J Pathol. 2007 Jan;170(1):1-15
pubmed: 17200177
Clin Cancer Res. 2007 Jun 15;13(12):3499-506
pubmed: 17575212
Nat Rev Drug Discov. 2016 Jun;15(6):385-403
pubmed: 26775688
Oncol Rep. 2018 Feb;39(2):827-833
pubmed: 29251334
Histol Histopathol. 2017 Sep;32(9):917-928
pubmed: 27990624
Br J Cancer. 2003 Sep 15;89(6):1031-4
pubmed: 12966421
PLoS One. 2013;8(2):e57160
pubmed: 23451174
FEBS J. 2019 Sep;286(17):3299-3332
pubmed: 31287944
Oncogene. 2005 Feb 10;24(7):1212-9
pubmed: 15592519
Adv Exp Med Biol. 2019;1139:105-114
pubmed: 31134497
Integr Biol (Camb). 2015 May;7(5):498-512
pubmed: 25839068
Nat Commun. 2016 Nov 09;7:13322
pubmed: 27827359
Cell. 2014 Feb 27;156(5):1002-16
pubmed: 24581498
Cancer Res. 2012 Oct 1;72(19):5111-8
pubmed: 22865455
Int J Oncol. 2019 Jul;55(1):116-130
pubmed: 31059004
Pharmacol Ther. 2016 Mar;159:83-92
pubmed: 26808163

Auteurs

Dorina Belotti (D)

Laboratory of Tumor Microenvironment, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24126 Bergamo, Italy.

Denise Pinessi (D)

Laboratory of Tumor Microenvironment, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24126 Bergamo, Italy.

Giulia Taraboletti (G)

Laboratory of Tumor Microenvironment, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24126 Bergamo, Italy.

Classifications MeSH